Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,855 | 1,970 | 17:26 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | The commercialization of Bioretec's RemeOs Trauma Screw in the U.S. proceeds with the signing of new logistics agreement | 370 | PR Newswire | Bioretec Ltd Press release 20 November 2024 at 3:30 p.m. EET
TAMPERE, Finland, Nov. 20, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic... ► Artikel lesen | |
14.11. | Bioretec Ltd's business review January-September 2024: Launch of the RemeOs Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage | 99 | PR Newswire | Bioretec Ltd Company announcement 14 November 2024 at 8:45 a.m.
TAMPERE, Finland, Nov. 14, 2024 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-September... ► Artikel lesen | |
04.10. | Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs Spinal Interbody Cage | 315 | PR Newswire | TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ -- Bioretec updates its product development strategy by accelerating the product development of the RemeOs Spinal Interbody Cage, an innovative... ► Artikel lesen | |
04.10. | Inside information: Bioretec updates its financial targets | 270 | PR Newswire | Bioretec Ltd Company announcement 4 October 2024 at 2:31 p.m. EEST
TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ -- Bioretec Ltd announced today, 4 October 2024, that Bioretec's board... ► Artikel lesen | |
BIORETEC Aktie jetzt für 0€ handeln | |||||
20.09. | Bioretec's Shareholders' Nomination Board appointed | 272 | PR Newswire | TAMPERE, Finland, Sept. 20, 2024 /PRNewswire/ -- The following persons have been appointed to Bioretec's Shareholders' Nomination Board: Kustaa Poutiainen, Chair and Founder of Stephen Industries... ► Artikel lesen | |
15.08. | Bioretec Ltd's half-year report January-June 2024: RemeOs trauma screw controlled launch in the U.S. yielded expected positive clinical results | 387 | PR Newswire | Bioretec Ltd Company announcement 15 August 2024 at 8:00 a.m.
TAMPERE, Finland, Aug. 15, 2024 /PRNewswire/ -- This announcement is a summary of Bioretec Ltd's half-year report January-June... ► Artikel lesen | |
27.06. | Inside Information: Update for Bioretec's RemeOs Trauma Screw European Marketing Authorization | 231 | PR Newswire | TAMPERE, Finland, June 27, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, announces that according to the information received from the Notified Body... ► Artikel lesen | |
19.06. | Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs trauma screw: fracture healing confirmed in 100% of surgical procedures | 501 | PR Newswire | TAMPERE, Finland, June 19, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in biodegradable orthopedic implants, is pleased to announce that a number of cases have been performed around the... ► Artikel lesen | |
18.06. | Bioretec Appoints Frank Sarcone as Vice President of Sales for the US and a member of the Management Team | 361 | PR Newswire | Bioretec Ltd Press release 18 June 2024 at 9:00 a.m. EEST
TAMPERE, Finland, June 18, 2024 /PRNewswire/ -- Bioretec Ltd, a pioneer in biodegradable orthopedic implants, has, as of June... ► Artikel lesen | |
20.05. | Inside information: Alan Donze has been appointed as Bioretec's new CEO | 321 | PR Newswire | Bioretec Ltd Inside information 20 May 2024 at 6:00 p.m. EEST
TAMPERE, Finland, May 20, 2024 /PRNewswire/ -- Bioretec Ltd is pleased to announce that Mr. Alan Donze has been appointed... ► Artikel lesen | |
16.05. | Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses | 309 | PR Newswire | Bioretec Ltd Company announcement 16 May 2024 at 8:30 a.m.
TAMPERE, Finland, May 16, 2024 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-March... ► Artikel lesen | |
26.04. | Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors | 360 | PR Newswire | Bioretec Ltd Company announcement 26 April 2024 at 12:15 p.m. EEST
TAMPERE, Finland, April 26, 2024 /PRNewswire/ -- The Annual General Meeting of Bioretec Ltd was held on 26 April 2024... ► Artikel lesen | |
05.04. | Notice of Annual General Meeting (AGM) of Bioretec Ltd | 378 | PR Newswire | Bioretec Ltd Company announcement 5 April 2024 at 3:00 p.m. EET
TAMPERE, Finland, April 5, 2024 /PRNewswire/ -- The shareholders of Bioretec Ltd are hereby invited to the Annual General... ► Artikel lesen | |
21.03. | Inside information: Bioretec's RemeOs biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office | 356 | PR Newswire | Bioretec Ltd Inside information 21 March 2024 at 7:00 p.m. EET
TAMPERE, Finland, March 21, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in biodegradable orthopedic implants, has been... ► Artikel lesen | |
15.03. | Bioretec Ltd's Annual Report and Financial Statements 2023 published | 395 | PR Newswire | Bioretec Ltd Company announcement 15 March 2024 at 5:30 p.m. EET
TAMPERE, Finland, March 15, 2024 /PRNewswire/ -- Bioretec Ltd has today published its 2023 Annual Report, Financial Statements... ► Artikel lesen | |
14.03. | Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs Spinal Interbody Cage | 385 | PR Newswire | TAMPERE, Finland, March 14, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in biodegradable orthopedic implants, has today been granted Breakthrough Device Designation for its RemeOs Spinal... ► Artikel lesen | |
08.03. | Inside information: Bioretec's European market authorization for RemeOs trauma screw has proceeded to expert panel evaluation, the approval is estimated during the Q2 2024 | 807 | PR Newswire | Bioretec Ltd Inside information 8 March 2024 at 9:15 p.m. EET
TAMPERE, Finland, March 8, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants,... ► Artikel lesen | |
16.02. | Bioretec Ltd's financial statements bulletin 2023: Another successful year in the growth trajectory | 294 | PR Newswire | Bioretec Ltd Company announcement 16 February 2024 at 8:00 a.m.
TAMPERE, Finland, Feb. 16, 2024 /PRNewswire/ -- This announcement is a summary of Bioretec Ltd's financial statements... ► Artikel lesen | |
05.01. | Bioretec Ltd - Managers' transactions | 384 | PR Newswire | Bioretec Ltd Managers' transactions 5 January 2024 at 11.00 a.m. EET
TAMPERE, Finland, Jan. 5, 2024 /PRNewswire/ --
Bioretec Oy - Managers' Transactions
Person subject to... ► Artikel lesen | |
11.12.23 | Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy | 308 | PR Newswire | Bioretec Ltd Company announcement 11 December 2023 at 5:15 p.m. EET
TAMPERE, Finland, Dec. 11, 2023 /PRNewswire/ -- In the future, in addition to the financial statements bulletin and... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 37,060 | -0,22 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler mit starken Neunmonatszahlen 2024 weiter auf Wachstumskurs | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): 9-Monatszahlen
Eckert & Ziegler mit starken Neunmonatszahlen 2024 weiter auf Wachstumskurs
14.11.2024 / 07:45 CET/CEST
Für... ► Artikel lesen | |
CYTOSORBENTS | 0,877 | +0,46 % | CytoSorbents; Converge Biotech: CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India | PRINCETON, N.J. and HYDERABAD, India, Nov. 11, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit... ► Artikel lesen | |
OPTOMED | 4,015 | +1,90 % | OPTOMED OYJ: Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings | ||
FRESENIUS | 32,710 | +1,55 % | Fresenius SE Aktie: Strukturelle Veränderungen? | Die Fresenius SE-Aktie verzeichnete am Handelstag Schwankungen im XETRA-Handel. Während der Wert zunächst mit leichten Gewinnen in den Tag startete, drehte er im Verlauf ins Minus. Gegen Mittag notierte... ► Artikel lesen | |
GERRESHEIMER | 70,45 | +0,43 % | Aixtron, Gerresheimer, Hugo Boss, K+S, Lufthansa, Rheinmetall u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 49,170 | -1,07 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers nach einer Investorenveranstaltung mit einem Kursziel von 65,90 Euro auf "Overweight" belassen. Die Themen... ► Artikel lesen | |
CARL ZEISS MEDITEC | 55,00 | -3,34 % | Carl Zeiss Meditec Aktie: Planänderungen erforderlich | Die Carl Zeiss Meditec-Aktie verzeichnete am Handelstag einen deutlichen Kursrückgang. Im XETRA-Handel fiel der Aktienkurs um 2,3 Prozent auf 56,65 Euro, nachdem er bei Börseneröffnung noch bei 58,65... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 41,440 | +1,57 % | DZ BANK stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für FMC von 37 auf 41 Euro angehoben und die Einstufung auf "Halten" belassen. Der Dialyseanbieter habe ein gelungenes Quartal hinter sich... ► Artikel lesen | |
TEMPUS AI | 53,55 | -7,87 % | Cathie Wood's ARK ETFs Adjust Portfolio with Notable Tesla and Tempus AI Stock Trades | ||
RESMED | 229,30 | 0,00 % | ResMed partners EDB to expand Singapore operations | ||
INTUITIVE SURGICAL | 522,80 | +1,69 % | Unglaubliche Prognose für Montag setzt Intuitive Surgical Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
NANO-X IMAGING | 5,760 | -2,21 % | Nano-X Imaging Ltd reports results for the quarter ended September 30 - Earnings Summary | ||
GENEDX | 73,38 | +5,73 % | GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $8,973,629.96 in Stock | ||
HIMS & HERS HEALTH | 21,990 | +6,33 % | Starke Konkurrenz befürchtet: Hims & Hers: Katastrophaler Crash nach Allzeithoch! | © Foto: UnsplashDie Anteile der Online-Apotheke Hims & Hers stehen unter Druck, nachdem E-Commerce-Riese Amazon angekündigt hat, einen Telemedizin-Service zu starten.Hinter der Aktie der US-Online-Apotheke... ► Artikel lesen | |
SEMLER SCIENTIFIC | 67,00 | +18,58 % | Semler Scientific stock hits 52-week high at $58.94 |